FFA
VNDA icon

Farther Finance Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Farther Finance Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.8K Sell
2,608
-371
-12% -$1.99K ﹤0.01% 4466
2026
Q2 		$18.2K Buy
2,979
+671
+29% +$4.38K ﹤0.01% 4041
2026
Q1 		$16.3K Buy
2,308
+366
+19% +$2.82K ﹤0.01% 3791
2025
Q4 		$17.1K Sell
1,942
-18
-0.9% -$99 ﹤0.01% 3540
2025
Q3 		$9.78K Buy
1,960
+300
+18% +$1.39K ﹤0.01% 3456
2025
Q2 		$7.83K Buy
1,660
+1,435
+638% +$6.28K ﹤0.01% 3198
2025
Q1 		$1.01K Sell
225
-303
-57% -$1.41K ﹤0.01% 3611
2024
Q4 		$2.53K Hold
528
– – ﹤0.01% 2913
2024
Q3 		$2.48K Buy
528
+48
+10% +$257 ﹤0.01% 2917
2024
Q2 		$2.68K Buy
480
+287
+149% +$1.48K ﹤0.01% 2671
2024
Q1 		$795 Sell
193
-262
-58% -$1.05K ﹤0.01% 2861
2023
Q4 		$1.92K Buy
455
+297
+188% +$1.2K ﹤0.01% 2445
2023
Q3 		$683 Sell
158
-23
-13% -$128 ﹤0.01% 2183
2023
Q2 		$1.19K Buy
181
+23
+15% +$147 ﹤0.01% 1915
2023
Q1 		$1.07K Sell
158
-48
-23% -$337 ﹤0.01% 1826
2022
Q4 		$1.52K Buy
+206
New +$2.01K ﹤0.01% 1539

Other funds holding VNDA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
CFS
CGC Financial Services Lake Oswego, Oregon $451M AUM 11.72% 1-Year Est. Return

Farther Finance Advisors's VNDA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Vanda Pharmaceuticals (VNDA) stake by 12% in Q3 2026, selling an estimated $1.99K and leaving 2,608 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4466.

Farther Finance Advisors first reported a position in VNDA in Q4 2022 and has held it in 16 quarters since. The position peaked at $18.2K in Q2 2026. 9 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.

  • Farther Finance Advisors held 2,608 shares of Vanda Pharmaceuticals worth $12.8K as of Q3 2026.
  • Farther Finance Advisors sold 371 Vanda Pharmaceuticals shares in Q3 2026, an estimated $1.99K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4466 holding.
  • Farther Finance Advisors first reported a position in Vanda Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Vanda Pharmaceuticals position peaked at $18.2K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.